# Comparative effectiveness of exercise modalities and nutritional supplementation for sarcopenic obesity in older adults: a network meta-analysis based on randomized controlled trials

**Authors:** Jiacheng Yu, Xinchun Li, Hao Yu, Yijun Huang

PMC · DOI: 10.3389/fpubh.2026.1775783 · Frontiers in Public Health · 2026-02-23

## TL;DR

This study compares different exercise and nutrition strategies for treating sarcopenic obesity in older adults, finding that resistance and multicomponent training are most effective.

## Contribution

The study provides a network meta-analysis comparing multiple rehabilitation strategies for sarcopenic obesity, offering ranked efficacy insights.

## Key findings

- Resistance training most effectively improves handgrip strength and reduces fat mass.
- Multicomponent training is best for reducing BMI and percentage body fat.
- No intervention significantly improved skeletal muscle index compared to usual care.

## Abstract

Sarcopenic obesity is highly prevalent among older adults and is associated with adverse clinical outcomes. However, direct comparative evidence on the relative efficacy and safety of different exercise-based rehabilitation strategies, with or without nutritional supplementation or high-protein intake, remains limited. This study aimed to compare and rank the effects of diverse rehabilitation interventions using a systematic review and network meta-analysis.

PubMed, Embase, the Cochrane Library, and Web of Science were systematically searched from database inception to November 1, 2025, without language restrictions. Both Medical Subject Headings and free-text terms were used. Primary outcomes included body mass index (BMI), handgrip strength (GRIP), fat mass (FM), percentage body fat (PBF), and skeletal muscle index (SMI). A systematic review and network meta-analysis were conducted. Risk of bias was assessed using the Cochrane Risk of Bias 2 (ROB 2) tool, and the certainty of evidence was evaluated using the CINeMA framework. The study protocol was prospectively registered in PROSPERO (CRD420251270452).

Twenty-four randomized controlled trials involving 1,298 participants and nine distinct exercise- and nutrition-related rehabilitation strategies were included. For BMI, only multicomponent training (MC) significantly reduced BMI compared with usual care (UC) (MD = −1.08, 95% CI −1.86 to −0.29) and ranked highest (SUCRA 85.1%). For handgrip strength, both resistance training (RT) (MD = 3.96, 95% CI 2.15–5.77) and MC (MD = 2.13, 95% CI 0.25–4.01) were superior to UC, with RT ranking first (SUCRA 90.9%). For fat mass, only RT significantly reduced FM compared with UC (MD = −2.30, 95% CI −3.63 to −0.98) and achieved the highest ranking (SUCRA 79.0%). For PBF, both MC (MD = −3.53, 95% CI −5.70 to −1.36) and RT (MD = −2.30, 95% CI −3.98 to −0.62) were effective, with MC ranking highest (SUCRA 77.1%). No intervention demonstrated a statistically significant advantage over UC for SMI; however, MC combined with nutritional supplementation ranked relatively favorably (SUCRA 74.1%). Global consistency testing supported overall network coherence. Sensitivity analyses confirmed the robustness of the findings, and comparison-adjusted funnel plots indicated no clear evidence of publication bias.

In older adults with sarcopenic obesity, exercise-centered interventions yield clinically meaningful benefits across several key rehabilitation outcomes. Overall, resistance training appears particularly effective for improving muscle strength and reducing adiposity-related measures, whereas multicomponent training shows greater advantages in reducing BMI and PBF. Evidence for improvements in SMI remains limited and uncertain, highlighting the need for larger, well-designed randomized trials with longer follow-up and direct head-to-head comparisons to clarify long-term benefits and identify optimal intervention combinations.

https://www.crd.york.ac.uk/PROSPERO/view/CRD420251270452, PROSPERO: CRD420251270452.

## Full-text entities

- **Genes:** GRIP1 (glutamate receptor interacting protein 1) [NCBI Gene 23426] {aka FRASRS3, GRIP}
- **Diseases:** functional impairment (MESH:D003072), loss of lean mass (MESH:D013851), musculoskeletal injury (MESH:D009140), adiposity (MESH:D018205), knee or hip osteoarthritis (MESH:D020370), osteoporosis (MESH:D010024), insulin resistance (MESH:D007333), UC (MESH:D054990), NS (MESH:D044342), metabolic complications (MESH:D020739), muscle hypertrophy (MESH:C536106), FM (MESH:C536030), SMI (MESH:D005207), PBF (MESH:D004620), overweight (MESH:D050177), falls (MESH:C537863), Sarcopenic obesity (MESH:D009765), cardiopulmonary limitations (MESH:D006323), muscle weakness (MESH:D018908), inflammation (MESH:D007249), Sarcopenia (MESH:D055948), metabolic syndrome (MESH:D024821)
- **Chemicals:** lipid (MESH:D008055), isoflavones (MESH:D007529), amino acid (MESH:D000596), MC (-), essential amino acids (MESH:D000601), leucine (MESH:D007930), vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967945/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967945/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967945/full.md

---
Source: https://tomesphere.com/paper/PMC12967945